No full text
Poster (Scientific congresses and symposiums)
18F-FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model.
Becker, Guillaume; Bahri, Mohamed Ali; Michel, Anne et al.
2015European Molecular Imaging Meeting EMIM 2015
 

Files


Full Text
No document available.
Full Text Parts
Abstract EMIM 2015 FMT.pdf
Author postprint (183.02 kB)
Abstract
Request a copy
FMT_Poster_EMIM_2015.pdf
Author postprint (567.99 kB)
Poster
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
[18F]FMT; Parkinson's disease; preclinical imaging; dopaminergic dysfunction; rat model
Abstract :
[en] Objectives: Rat models of Parkinson’s disease (PD), such as lesioned rats with 6-hydroxydopamine (6-OHDA), are useful for studying dopamine (DA)-related functions. 6-18F-fluoro-m-tyrosine (6-18F-FMT) is an effective PET tracer to evaluate of DA terminals integrity and L-aromatic amino acid decarboxylase (AAAD) metabolic pathway. However, there are currently no available quantitative PET studies using 18F-FMT in 6-OHDA lesioned rats. In this context, we investigated the feasibility of in vivo PET study using 18F-FMT on 6-OHDA PD’s model. Methods: 10 µg of 6-OHDA were injected into the right medial forebrain bundle (MFB) of male Sprague-Dawley rats (n=8). As control, sham-treated rats (n=8) were injected with vehicle only but otherwise treated identically. Striatal DA presynaptic activity was assessed by dynamic 18F-FMT-PET. Structural T2-weighted brain images were acquired on a 9.4T MRI and were used for co-registration. After normalization on a MRI template, kinetic analysis was performed by “Patlak Reference” model, using PMOD software. Results: Striatal accumulation of 18F-FMT was observed in rats pretreated with benserazide, a peripheral AAAD inhibitor. As consequence of the 6-OHDA-lesion, significant decrease of 18F-FMT accumulation was recorded in the striatum ipsilateral to the lesion. Lesioned rats had dramatically reduced uptake constant Ki in the ipsilateral striatum compared to the contralateral striatum (p<0.001) and to the ipsilateral striatum of sham-treated rats (p<0.005). The Ki ratio (Ipsi./Contra.) was equivalent to 94% in the sham group and dropped to 41% in the lesioned group. Conclusions: 18F-FMT PET enables us to quantify loss of DA presynaptic function in unilaterally 6-OHDA lesioned rats. These results encourage us to pursue further investigations in a longitudinal way and to monitor the progression of the dopaminergic dysfunction in more moderate and gradual preclinical PD models.
Research center :
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Becker, Guillaume ;  Université de Liège > Centre de recherches du cyclotron
Bahri, Mohamed Ali  ;  Université de Liège > Centre de recherches du cyclotron
Michel, Anne
Hustadt, F
Garraux, Gaëtan  ;  Université de Liège > Département des sciences biomédicales et précliniques > Biochimie et physiologie du système nerveux
Lemaire, Christian ;  Université de Liège > Centre de recherches du cyclotron
Plenevaux, Alain  ;  Université de Liège > Centre de recherches du cyclotron
Language :
English
Title :
18F-FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model.
Publication date :
18 March 2015
Number of pages :
A0
Event name :
European Molecular Imaging Meeting EMIM 2015
Event organizer :
European Society for Molecular Imaging
Event place :
Tübingen, Germany
Event date :
18-20 March 2015
Audience :
International
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Available on ORBi :
since 16 November 2015

Statistics


Number of views
69 (7 by ULiège)
Number of downloads
2 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi